Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer

Up to 20% of cancer patients will develop some manifestation of venous thromboembolic disease (VTD) during their clinical course. VTD greatly impacts morbidity, mortality, quality of life and pharmaceutical expenditure. In addition, both thrombotic relapse and major haemorrhages derived from VTD tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Quintanar, T., Font, C., Gallardo, E., Barba, R., Obispo, B., Díaz-Pedroche, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979662/
https://www.ncbi.nlm.nih.gov/pubmed/32885400
http://dx.doi.org/10.1007/s12094-020-02477-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979662/
https://www.ncbi.nlm.nih.gov/pubmed/32885400
http://dx.doi.org/10.1007/s12094-020-02477-6

Ejemplares similares